Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MKS Instruments (MKSI) vs Nuwellis Inc (NUWE) Price & Performance

MKS InstrumentsTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

MKS Instruments vs Nuwellis Inc — how do they compare? MKS Instruments trades at $268.04 (market cap $17.95B), while Nuwellis Inc trades at $0.8 (market cap $2.50M). The key difference: MKS Instruments is far larger — about 7180× Nuwellis Inc's market cap, and MKS Instruments pays a 0.38% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.

MKSINUWE
Market Cap
$17.95B$2.50M
Sector
TechnologyTechnology
52-Week High
$444.80$164.50
52-Week Low
$110.60$0.73
Enterprise Value
$21.53B-$1.21M
Dividend Yield
0.38%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MKS Instruments

No Aura AI signal available yet.

Nuwellis Inc

NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.

While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.

Returns comparison

Trailing returns across standard periods

About MKS Instruments

MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.

Read more on MKSI

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE